We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.48%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.8B
AUM Growth
+$629M
Cap. Flow
-$312M
Cap. Flow %
-2.1%
Top 10 Hldgs %
24.14%
Holding
917
New
50
Increased
256
Reduced
457
Closed
57

Top Buys

Rank Stock Value
1
VERU icon
Veru
VERU
+$53M
2
MELI icon
Mercado Libre
MELI
+$43.2M
3
DAR icon
Darling Ingredients
DAR
+$41.7M
4
JNJ icon
Johnson & Johnson
JNJ
+$33.7M
5
MET icon
MetLife
MET
+$31.1M

Top Sells

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$46.1M
2
NKE icon
Nike
NKE
+$36.6M
3
ITW icon
Illinois Tool Works
ITW
+$35.8M
4
AAPL icon
Apple
AAPL
+$31.9M
5
GILD icon
Gilead Sciences
GILD
+$29.8M

Sector Composition

Rank Sector Weight
1 Healthcare 33.32%
2 Technology 22.84%
3 Financials 10.04%
4 Consumer Discretionary 7.69%
5 Industrials 7.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WBD icon
476
Warner Bros
WBD
$65.9B
$3.1M 0.02%
327,085
-45,026
-12% -$508K
AMP icon
477
Ameriprise Financial
AMP
$48.3B
$3.1M 0.02%
9,944
-1,388
-12% -$423K
WY icon
478
Weyerhaeuser
WY
$18B
$3.07M 0.02%
99,127
-6,538
-6% -$203K
GEN icon
479
Gen Digital
GEN
$16.4B
$3.04M 0.02%
142,022
-2,948
-2% -$65.1K
MFC icon
480
Manulife Financial
MFC
$73.9B
$3M 0.02%
168,389
-41,479
-20% -$707K
VC icon
481
Visteon
VC
$2.79B
$2.99M 0.02%
+22,868
New +$3.05M
PXD
482
DELISTED
Pioneer Natural Resource Co.
PXD
$2.95M 0.02%
12,932
+851
+7% +$207K
STT icon
483
State Street
STT
$50.6B
$2.95M 0.02%
38,027
-1,147
-3% -$84.5K
LYV icon
484
Live Nation Entertainment
LYV
$40.6B
$2.95M 0.02%
42,264
-2,851
-6% -$211K
WTRG icon
485
Essential Utilities
WTRG
$11.3B
$2.94M 0.02%
61,656
+5,037
+9% +$228K
IAA
486
DELISTED
IAA, Inc. Common Stock
IAA
$2.88M 0.02%
+72,041
New +$2.72M
PFG icon
487
Principal Financial Group
PFG
$24.3B
$2.84M 0.02%
33,862
-3,179
-9% -$273K
SWAV
488
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$2.84M 0.02%
13,811
+2,513
+22% +$635K
NTRS icon
489
Northern Trust
NTRS
$33.3B
$2.83M 0.02%
31,982
-22,108
-41% -$1.94M
EIX icon
490
Edison International
EIX
$28.2B
$2.81M 0.02%
44,193
+1,426
+3% +$87.5K
FRC
491
DELISTED
First Republic Bank
FRC
$2.79M 0.02%
22,889
-4,682
-17% -$571K
CLX icon
492
Clorox
CLX
$11.6B
$2.77M 0.02%
19,755
-1,502
-7% -$213K
EXPD icon
493
Expeditors International
EXPD
$22B
$2.75M 0.02%
26,468
-1,773
-6% -$183K
AVTR icon
494
Avantor
AVTR
$9.32B
$2.73M 0.02%
129,432
+59,960
+86% +$1.24M
M icon
495
Macy's
M
$6.53B
$2.71M 0.02%
131,458
-402,491
-75% -$8.24M
AME icon
496
Ametek
AME
$55.4B
$2.71M 0.02%
19,398
-2,605
-12% -$345K
IGMS
497
DELISTED
IGM Biosciences
IGMS
$2.7M 0.02%
158,985
+110,225
+226% +$2.2M
SWKS icon
498
Skyworks Solutions
SWKS
$9.37B
$2.69M 0.02%
29,481
-983
-3% -$88.1K
CDW icon
499
CDW
CDW
$18.9B
$2.69M 0.02%
15,039
-17,870
-54% -$3.14M
CP icon
500
Canadian Pacific Kansas City
CP
$78.1B
$2.67M 0.02%
35,831
+18,818
+111% +$1.42M

Similar funds

Candriam SCA's Q4 2022 Portfolio in Review

As of Q4 2022, Candriam SCA held 917 positions worth $14.8B, up 4.4% from $14.2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Candriam SCA's Q4 2022 filing shows 50 new, 256 increased, 457 reduced and 57 closed positions. Its largest new stake was Sarepta Therapeutics: 95,144 shares worth $12.3M. The largest sale was PepsiCo, an estimated $46.1M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 32% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q4 2022 buy was Sarepta Therapeutics: 95,144 shares worth $12.3M.
  • Candriam SCA added most to Veru in Q4 2022, an estimated $53M increase.
  • Candriam SCA's biggest Q4 2022 reduction was PepsiCo, cutting an estimated $46.1M.
  • Candriam SCA fully exited Global Blood Therapeutics, Inc. in Q4 2022, selling an estimated $24.6M.
  • Candriam SCA's ten largest holdings make up 24% of its $14.8B portfolio in Q4 2022.
  • Candriam SCA opened 50 new positions and closed 57 in Q4 2022.
  • Candriam SCA's portfolio value rose 4.4% quarter-over-quarter to $14.8B.

Based on Candriam SCA's 13F filing for Q4 2022, filed 13 Feb 2023.